Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
SITE SPECIFIC DOSING OF A BTK INHIBITOR
No-Receipt date
2021-00316 - 27/01/2021
No-Filing date
20210400220 - 27/01/2021
No-Granting date
3106195 - 04/02/2021
No-EPO application date
15826209.7 - 23/12/2015
No-EPO granting date
3236953 - 11/11/2020
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
2/2021 - 16/03/2021
Expiration date
24/12/2035
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US201462096809 P24/12/2014/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 9/50
A61K 9/48
A61K 9/28
A61K 31/519
A61K 31/506
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1260948
PRINCIPIA BIOPHARMA INC.
220 E. GRAND AVE.
S. SAN FRANCISCO, CA 94080
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
3219481
NUNN, PHILIPP
3219482
BERNER, BRET
3219483
MASJEDIZADEH, MOHAMMAD
Representatives
Code
Firstname
Surname
Address
Town
Zip
2011
VALI-VASILIKI
SAKELLARIDI
ADRIANOY 70
ATHINA (ATTIKIS)
10556
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
5848
VALI-VASILIKI
SAKELLARIDI
ADRIANOY 70
ATHINA (ATTIKIS)
10556
GREECE
Owners History
Title Instruments
Payments history
10 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).